Open Innovation: The New Imperative for Creating and Profiting from Technology
Harvard Business Press, 2006 - 227 páginas
In todays information-rich environment, companies can no longer afford to rely entirely on their own ideas to advance their business, nor can they restrict their innovations to a single path to market. As a result, says Harvard Business School professor Henry W. Chesbrough, the traditional model for innovation--which has been largely internally focused, closed off from outside ideas and technologies--is becoming obsolete. Emerging in its place is a new paradigm, open innovation, which strategically leverages internal and external sources of ideas and takes them to market through multiple paths. This path-breaking analysis is based on extensive field research, academic study, and the authors own longtime experience working in Silicon Valley. Through rich descriptions of the innovation processes of Xerox, IBM, Lucent, Intel, Merck, and Millennium, and the many spin-offs that have emerged from these firms, Open Innovation shows how companies can use their business model to identify a more enlightened role for R&D in a world of abundant information, better manage and access intellectual property, advance their current business, and grow their future business. Arguing that companies in all industries must transform the way they commercialize knowledge, Chesbrough convincingly shows how open innovation can unlock the latent economic value in a companys ideas and technologies.
Comentarios de usuarios - Escribir una reseña
Puntuaciones de los usuarios
Open Innovation: The New Imperative for Creating and Profiting from TechnologyReseña de usuario - Not Available - Book Verdict
The great corporate research departments at companies like Bell Labs, IBM and Xerox were once the motor of American industry. But that may be changing, according to this probing academic study of ... Leer reseña completa
Las empresas que no innovan, mueren.
Otras ediciones - Ver todo
Non-representational Theory: Space, Politics, Affect
N. J. Thrift
No hay ninguna vista previa disponible - 2008
Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the ...
Oliver Gassmann,Gerrit Reepmeyer,Maximilian von Zedtwitz
Vista previa restringida - 2008